Mizutani T - Search Results

1

Depressed plasma activity of plasminogen or alpha2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.

Asakura H, Ontachi Y, Mizutani T, Kato M, Ito T, Saito M, Morishita E, Yamazaki M, Suga Y, Miyamoto KI, Nakao S. Asakura H, et al. Among authors: mizutani t. Blood Coagul Fibrinolysis. 2001 Jun;12(4):275-81. doi: 10.1097/00001721-200106000-00008. Blood Coagul Fibrinolysis. 2001. PMID: 11460011

2

All-trans retinoic acid is partially effective against lipopolysaccharide-induced but not against tissue-factor-induced disseminated intravascular coagulation in rat models.

Asakura H, Aoshima K, Ichino T, Suga Y, Saito M, Morishita E, Yamazaki M, Ontachi Y, Mizutani T, Kato M, Miyamoto KI, Nakao S. Asakura H, et al. Among authors: mizutani t. Blood Coagul Fibrinolysis. 2001 Jun;12(4):301-6. doi: 10.1097/00001721-200106000-00011. Blood Coagul Fibrinolysis. 2001. PMID: 11460014

3

Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.

Asakura H, Ontachi Y, Mizutani T, Kato M, Ito T, Saito M, Morishita E, Yamazaki M, Aoshima K, Takami A, Yoshida T, Suga Y, Miyamoto K, Nakao S. Asakura H, et al. Among authors: mizutani t. Eur J Haematol. 2001 Sep;67(3):170-5. doi: 10.1034/j.1600-0609.2001.5790508.x. Eur J Haematol. 2001. PMID: 11737250

4

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.

Asakura H, Ichino T, Yoshida T, Suga Y, Ontachi Y, Mizutani T, Kato M, Ito T, Yamazaki M, Aoshima K, Morishita E, Saito M, Miyamoto KI, Nakao S. Asakura H, et al. Among authors: mizutani t. Blood Coagul Fibrinolysis. 2002 Apr;13(3):233-9. doi: 10.1097/00001721-200204000-00009. Blood Coagul Fibrinolysis. 2002. PMID: 11943937

5

Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases.

Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Morishita E, Yamazaki M, Suga Y, Takami A, Miyamoto K, Nakao S. Asakura H, et al. Among authors: mizutani t. Blood Coagul Fibrinolysis. 2001 Jan;12(1):1-8. doi: 10.1097/00001721-200101000-00001. Blood Coagul Fibrinolysis. 2001. PMID: 11229821

6

An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.

Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Nakao S. Asakura H, et al. Among authors: mizutani t. Crit Care Med. 2001 Jun;29(6):1164-8. doi: 10.1097/00003246-200106000-00015. Crit Care Med. 2001. PMID: 11395595

7

Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model.

Aoshima K, Asakura H, Yamazaki M, Saito M, Kumabashiri I, Morishita E, Ontachi Y, Mizutani T, Ichino T, Matsuda T. Aoshima K, et al. Among authors: mizutani t. Semin Thromb Hemost. 1998;24(3):227-31. doi: 10.1055/s-2007-995846. Semin Thromb Hemost. 1998. PMID: 9701452

8

Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression.

Yamazaki M, Aoshima K, Mizutani T, Ontachi Y, Saito M, Morishita E, Asakura H, Matsuda T, Triplett DA. Yamazaki M, et al. Among authors: mizutani t. Blood Coagul Fibrinolysis. 1999 Sep;10(6):321-30. doi: 10.1097/00001721-199909000-00002. Blood Coagul Fibrinolysis. 1999. PMID: 10493213

9

Vitamin K administration to elderly patients with osteoporosis induces no hemostatic activation, even in those with suspected vitamin K deficiency.

Asakura H, Myou S, Ontachi Y, Mizutani T, Kato M, Saito M, Morishita E, Yamazaki M, Nakao S. Asakura H, et al. Among authors: mizutani t. Osteoporos Int. 2001 Dec;12(12):996-1000. doi: 10.1007/s001980170007. Osteoporos Int. 2001. PMID: 11846334 Clinical Trial.

10

[A point mutation at Arg169 (CGG-->TGG) in hereditary protein C deficiency].

Morishita E, Asakura H, Saito M, Yamazaki M, Ontachi Y, Mizutani T, Kato M, Nakao S. Morishita E, et al. Among authors: mizutani t. Rinsho Ketsueki. 2001 Feb;42(2):104-9. Rinsho Ketsueki. 2001. PMID: 11280915 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,828 results

Search Page